This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
We report the use of bevacizumab (Avastin) as an additional strategy in angle closure glaucoma based on the case of 47 years
old male qualified to cataract removal as anti-glaucoma procedure in whom we observed iris and lens neovascularization.
As a first step we administered 1.25 mg of bevacizumab into the anterior chamber. Iris as well as lens neovasularization completely
disappeared 48 hours later. Finally after lens removal we achieved deeper anterior chamber, reduction and stabilization of
intraocular pressure without necessity of hipotensive agent?s administration and improvement of visual acuity.
Joanna Liput has completed postdoctoral studies and her Ph.D at the age of 29 years from Wroclaw Medical University, Poland. She has published
more than 25 papers in national and international journals. In 2006 granted by European Board of Ophthalmology. Currently works at Great Western
Hospital in Swindon, UK.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals